Restylane Lyft with Lidocaine for Chin Augmentation
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants receive initial treatment with Restylane Lyft with Lidocaine in the chin region at Baseline
Touch-up Treatment (optional)
Participants may receive an optional touch-up treatment 1 month after initial treatment
Retreatment (optional)
Participants may receive an optional retreatment 12 months after the last treatment
Follow-up
Participants are monitored for safety and effectiveness after the optional retreatment
What Are the Treatments Tested in This Trial?
Interventions
- Restylane Lyft with Lidocaine
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will receive initial treatment with Restylane Lyft with Lidocaine in the chin region at Baseline with an optional touch-up treatment at 1 month after initial treatment and an optional retreatment 12 months after the last treatment.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Galderma R&D
Lead Sponsor
Flemming Ørnskov
Galderma R&D
Chief Executive Officer since 2019
MD, MPH
Baldo Scassellati Sforzolini
Galderma R&D
Chief Medical Officer
MD, PhD
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.